A 49-year-old patient came to the hospital with pyelonephritis and high fever. He was treated for non-muscleinvasive bladder cancer with Bacillus Calmette-Gué rin instillations. An abdominal contrast-enhanced computed tomography was obtained, revealing rounded masses of low-density in the left kidney. Several tests were performed, confirming mycobacterial infection. The patient was successfully treated.
Learning point for clinicians
A 49-year-old patient came to the hospital with pyelonephritis and high fever. He was treated for non-muscleinvasive bladder cancer with Bacillus Calmette-Gué rin instillations. An abdominal contrast-enhanced computed tomography was obtained, revealing rounded masses of low-density in the left kidney. Several tests were performed, confirming mycobacterial infection. The patient was successfully treated.
Case presentation
A 49-year-old man underwent a transurethral resection of non-muscle-invasive bladder cancer (NMIBC) T1N0M0 followed by intravesical administration of doxorubicin in September 2017. In October he received two instillations of Bacillus Calmette-Gué rin (BCG), then at the end of November he underwent the second transurethral resection followed by intravesical administration of doxorubicin once again. While being on the second round of instillations, the patient had experienced an episode of nephrocolic with macrohematuria at fourth instillation, and after fifth instillation fever had emerged up to 39.1 C with lumbar pain complementing dysuria's symptoms, that had not responded to antibiotics. Due to persisting fever, isoniazid in 0.3 g dosage was considered, which was resulted in fever resolution. The patient was referred then to our hospital, where a contrast-enhanced abdominal computed tomography exam was obtained.
It had shown multiple rounded hypodense masses, variable in size, in the left kidney without any contrast enhancement and deformation in paranephric adipose tissue (Figures 1  and 2) .
A US-assisted biopsy of the left kidney was then performed, but results came mycobacterium-negative, but polymerase chain reaction test for Mycobacterii tuberculosis was positive.
The patient received standard four-drug regimen (isoniazid 600 mg, rifampicin 600 mg, pyrazinamide 1500 mg and ethambutol 1200 mg) after for 8 weeks, and then rifampicin 600 mg and isoniazid 600 mg were assigned for continuation phase. With such therapy the patient showed prominent improvement clinically and radiologically and discharged.
Discussion
Intravesical BCG instillations have been considered as a highly effective treatment for intermediate and high-grade NMIBC but not low-grade due to its less favourable risk-versus-benefit profile. Induction and maintenance BCG therapy are recommended for the treatment regimen. The optimal dose of BCG and duration along with the frequency of BCG instillations are unknown. The practice has shown, however, that at least 1 year of BCG therapy for intermediate-risk NMIBC and at least 3 years of therapy for high-risk NMIBC are highly effective. 1 Despite its weakened state, BCG has the ability to become active and cause multisystem disease in treated patients. Although well tolerated by the majority of patients, the treatment has some undesirable complications including local dysuria, urgencyfrequency syndromes, fever, renal abscess, pneumonitis, reactive arthritis and severe systemic BCG sepsis with indices rate of 3-5% of all patients. 2, 3 Toxicity of BCG is related to the route of administration. Intravesical and oral administration have been reported to lack almost completely severe systemic complications, whilst anaphylactic reactions have been reported with intralesional injection.
It is important to emphasize not to administer BCG therapy to immunocompromised patients. In cases with previous tuberculosis history, there may be an underlying dormant tuberculous infection, so it is reasonable to provide antituberculous drug therapy.
Diagnosing BCG-related complications can be difficult. The clinical manifestations are usually postponed after the last BCG infusion. What is seen while analyzing radiological findings can resemble similar pictures of cancer or non-mycobacterial infection. 1 Renal tuberculosis is an extremely rare complication, anecdotal through all complication cases. Importantly, it can mimic a renal tumour on imaging. Clinicians should have a low index of suspicion and should consider renal biopsy prior to considering nephrectomy. If confirmed, primary treatment must be considered with antituberculosis therapy.
For a radiologist information of prior intravesical BCG treatment is the key to prospectively making the correct diagnosis, paving a road for clinicians to appropriate management.
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